Skip to main content
. Author manuscript; available in PMC: 2017 Sep 8.
Published in final edited form as: Cancer Res. 2017 May 22;77(14):3791–3801. doi: 10.1158/0008-5472.CAN-16-2545

Figure 2.

Figure 2

CD44s and HAS2 expression levels positively correlate in aggressive breast cancer subtypes from TCGA database. A, CD44s (left), but not CD44v (right), positively correlate with HAS2 in breast cancer specimens. B–F, Correlations of CD44s and HAS2 expression are shown in different subtypes of breast cancer.

HHS Vulnerability Disclosure